Monday, October 11, 2010

On the implications of the FDA's request to withdraw Meridia

The decision late last week by the FDA to encourage Abbott Laboratories to withdraw its Meridia diet pill has obvious implications for other drugmakers seeking approval for obesity drugs. Pharmalot has a comment on the subject here.

No comments: